Predicting age-specific dosing of antipsychotics

H. Uchida, B. G. Pollock, R. R. Bies, D. C. Mamo

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)


Antipsychotic medications are the standard of care for both acute and maintenance treatment of schizophrenia, the latter requiring an indefinite treatment across a patients life span. However, dosing and tolerability of antipsychotics have been studied primarily in younger patients, and very limited data are available for age- and phase-specific dosing. This leaves the clinician with no guidance on dose adjustment as patients grow olderan issue of critical importance, especially in light of recent concerns about increased morbidity and mortality associated with antipsychotics.

Original languageEnglish
Pages (from-to)360-362
Number of pages3
JournalClinical Pharmacology and Therapeutics
Issue number4
Publication statusPublished - 2009 Oct

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Predicting age-specific dosing of antipsychotics'. Together they form a unique fingerprint.

Cite this